R indica un producto altamente recomendado basado en la preferencia del cliente.
Empty Table Header | Nombre del producto | CATALOG # | Species | Aplicaciones | MARCADOR | MENCIONES | Clasificación |
---|---|---|---|---|---|---|---|
CRBP I siRNA (h) | sc-43699 | h | Gene Silencing | N/A | 0 | ||
CRBP I Plásmido shRNA (h) | sc-43699-SH | h | Gene Silencing | Puromycin | 0 | ||
CRBP I shRNA (h) Partículas Lentivirales | sc-43699-V | h | Gene Silencing | Puromycin | 0 | ||
CRBP I siRNA (m) | sc-60043 | m | Gene Silencing | N/A | 0 | ||
CRBP I Plásmido shRNA (m) | sc-60043-SH | m | Gene Silencing | Puromycin | 0 | ||
CRBP I shRNA (m) Partículas Lentivirales | sc-60043-V | m | Gene Silencing | Puromycin | 0 | ||
CRBP II siRNA (h) | sc-78318 | h | Gene Silencing | N/A | 0 | ||
CRBP II Plásmido shRNA (h) | sc-78318-SH | h | Gene Silencing | Puromycin | 0 | ||
CRBP II shRNA (h) Partículas Lentivirales | sc-78318-V | h | Gene Silencing | Puromycin | 0 | ||
CRBP II siRNA (m) | sc-142563 | m | Gene Silencing | N/A | 0 | ||
CRBP II Plásmido shRNA (m) | sc-142563-SH | m | Gene Silencing | Puromycin | 0 | ||
CRBP II shRNA (m) Partículas Lentivirales | sc-142563-V | m | Gene Silencing | Puromycin | 0 | ||
CRBP III siRNA (h) | sc-60440 | h | Gene Silencing | N/A | 0 | ||
CRBP III Plásmido shRNA (h) | sc-60440-SH | h | Gene Silencing | Puromycin | 0 | ||
CRBP III shRNA (h) Partículas Lentivirales | sc-60440-V | h | Gene Silencing | Puromycin | 0 | ||
CRBP IV siRNA (h) | sc-88028 | h | Gene Silencing | N/A | 0 | ||
CRBP IV Plásmido shRNA (h) | sc-88028-SH | h | Gene Silencing | Puromycin | 0 | ||
CRBP IV shRNA (h) Partículas Lentivirales | sc-88028-V | h | Gene Silencing | Puromycin | 0 | ||
CRBP IV (h)-PR | sc-88028-PR | h | Primer | N/A | 0 | ||
CRBP IV siRNA (m) | sc-105244 | m | Gene Silencing | N/A | 0 | ||
CRBP IV Plásmido shRNA (m) | sc-105244-SH | m | Gene Silencing | Puromycin | 0 | ||
CRBP IV shRNA (m) Partículas Lentivirales | sc-105244-V | m | Gene Silencing | Puromycin | 0 | ||
CRBP IV (m)-PR | sc-105244-PR | m | Primer | N/A | 0 |